SCHEMBL8076392

SCHEMBL8076392

O=C(O)c1ccc(C=C2c3cccc(O)c3C(=O)c3c(O)cccc32)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
HPGD P15428 3/20 0.55
TDP1 Q9NUW8 3/20 0.55
ALDH1A1 P00352 3/20 0.55
TTR P02766 2/20 0.55
LMNA P02545 2/20 0.55
ALOX15 P16050 2/20 0.55
TSHR P16473 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HSD17B10 Q99714 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
FTO Q9C0B1 2/20 0.55
KDM4E B2RXH2 1/20 0.55
BCHE P06276 1/20 0.55
POLB P06746 1/20 0.55
HSP90AA1 P07900 1/20 0.55
HSP90AB1 P08238 1/20 0.55
CYP3A4 P08684 1/20 0.55
THRB P10828 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8077733 0.86 MAPT (0.58) MAPTHPGDTDP1ALDH1A1TTR
SCHEMBL8062686 0.84 MAOA (0.56) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL8432574 0.83 AR (0.49) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL8076420 0.82 ALDH1A1 (0.53) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL6104911 0.79 LCK (0.67) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL8073094 0.78 AR (0.58)
SCHEMBL8071149 0.78 MAOA (0.49) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL8072577 0.78 MAOA (0.49) MAPTHPGDTDP1ALDH1A1LMNA
SCHEMBL20299406 0.78 MAPT (0.73) MAPTHPGDTDP1ALDH1A1SMN1; SMN2
SCHEMBL8078175 0.77 MAPT (0.51) MAPTHPGDTDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0664780-B1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMA (IL) 1999-12-08 EP claimed
US-6127426-A ANTIALLERGIC AND -INFLAMMATORY AGENTS E.G., TREATING PSORIASIS, BLOCKED ON THE C-10 BY A NONPHENOLIC ARYLACYL OR A PHENYLALKYLIDENE GROUP; LIPOXYGENASE INHIBITORS; ANTIPROLIFERATIVE AGENTS; LOW DOSAGE; SIDE EFFECT REDUCTION TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2000-10-03 US disclosed
EP-0664780-B1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMA (IL) 1999-12-08 EP disclosed
US-5952390-A ANTIINFLAMMATORY AGENTS; TREATMENT FOR PSORIASIS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1999-09-14 US disclosed
US-5844004-A 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1998-12-01 US disclosed
US-5661187-A ADMINISTERING TO TREAT AN ALLERGIC OR INFLAMMATORY CONDITION; SIDE EFFECT REDUCTION TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1997-08-26 US disclosed
EP-0664780-A1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1995-08-02 EP disclosed
WO-1995003266-A1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1995-02-02 WO disclosed